JI; Haitao

Patent Applications and Registrations

Patent applications and USPTO patent grants for JI; Haitao.The latest application filed is for "b-catenin/b-cell lymphoma 9 protein-protein interaction inhibiting peptidomimetics".

Company Profile

7.12.26

JI; Haitao - Tampa FL
JI; Haitao - Beijing CN
Ji; Haitao - Salt Lake City UT
Ji; Haitao - Evanston IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
B-catenin/b-cell Lymphoma 9 Protein-protein Interaction Inhibiting Peptidomimetics App 20220220153 - CAI; Jianfeng ; et al.	2022-07-14
Small Molecule Pyrin-domain Targeted Nlrp3 Inflammasome Inhibitors App 20220098188 - LIST; Alan ; et al.	2022-03-31
Peptidomimetic Inhibitors Of B-catenin/tcf Protein-protein Interaction App 20220024977 - JI; Haitao	2022-01-27
Beta-catenin And B-cell Lymphoma 9 (bcl9) Inhibitors App 20210380558 - JI; Haitao	2021-12-09
Beta-catenin And B-cell Lymphoma 9 (bcl9) Inhibitors App 20210340123 - JI; Haitao	2021-11-04
Real-time Localization Error Correction Of Autonomous Vehicle App 20210302168 - LIU; Xiaolong ; et al.	2021-09-30
Log structure with compressed keys Grant 11,113,159 - Zhang , et al. September 7, 2	2021-09-07
Stapled Peptides As Pyrin-domain Targeted Nlrp3 Inflammasome Inhibitors App 20210238228 - LIST; Alan ; et al.	2021-08-05
Inhibitors For The B-catenin/b-cell Lymphoma 9 (bcl9) Protein-protein Interaction App 20210179583 - JI; Haitao	2021-06-17
Methods And Composition Of 4-substituted Benzoylpiperazine-1-substituted Carbonyls As Beta-catenin/b-cell Lymphoma 9 Inhibitors App 20210171502 - Ji; Haitao ; et al.	2021-06-10
Inhibitors For The B-catenin/b-cell Lymphoma 9 (bcl9) Protein-protein Interaction App 20210078986 - Ji; Haitao	2021-03-18
Inhibitors For The B-catenin / T-cell Factor Protein-protein Interaction App 20210017139 - JI; Haitao	2021-01-21
Log Structure With Compressed Keys App 20200159629 - ZHANG; Zhiyuan ; et al.	2020-05-21
Network Interface Controller With Non-volatile Random Access Memory Write Packet Log App 20190332314 - ZHANG; Zhiyuan ; et al.	2019-10-31
Speculative Read Mechanism For Distributed Storage System App 20190310964 - ZHANG; Zhiyuan ; et al.	2019-10-10
Methods and compositions of substituted 5H-[1,2,5] oxadiazolo [3',4':5,6] pyrazino[2,3-B] indole analogs as inhibitors of .beta.-catenin/T-cell factor protein-protein interactions Grant 10,273,246 - Ji , et al.	2019-04-30
Methods And Compositions Of Substituted 5h-[1,2,5] Oxadiazolo [3',4':5,6] Pyrazino[2,3-b] Indole Analogs As Inhibitors Of Beta-catenin/t-cell Factor Protein-protein Interactions App 20180134729 - Ji; Haitao ; et al.	2018-05-17
Substituted N-([1,1'-biphenyl]-3-yl)-[1,1'-biphenyl]-3-carboxamide Analogs As Inhibitors For Beta-catenin/b-cell Lymphoma 9 Interactions App 20180092866 - Ji; Haitao ; et al.	2018-04-05
Substituted 1H-indazol-1-OL analogs as inhibitors of beta catenin/Tcf protein-protein interactions Grant 9,738,628 - Ji , et al. August 22, 2	2017-08-22
Substituted 1h-indazol-1-ol Analogs As Inhibitors Of Beta Catenin/tcf Protein-protein Interactions App 20160297801 - Ji; Haitao ; et al.	2016-10-13
Substituted 1H-indazol-1-ol analogs as inhibitors of beta catenin/Tcf protein-protein interactions Grant 9,284,299 - Ji , et al. March 15, 2	2016-03-15
Specific nNOS inhibitors for the therapy and prevention of human melanoma Grant 9,090,589 - Silverman , et al. July 28, 2	2015-07-28
Substituted 1h-indazol-1-ol Analogs As Inhibitors Of Beta Catenin/tcf Protein-protein Interactions App 20150025114 - Ji; Haitao ; et al.	2015-01-22
Specific nNOS Inhibitors for the Therapy and Prevention of Human Melanoma App 20140147920 - Meyskens, JR.; Frank L. ; et al.	2014-05-29
Inhibitors of nitric oxide synthase for treatment of melanoma Grant 8,642,282 - Meyskens, Jr. , et al. February 4, 2	2014-02-04
Selective neuronal nitric oxide synthase inhibitors Grant 8,557,552 - Silverman , et al. October 15, 2	2013-10-15
Selective Neuronal Nitric Oxide Synthase Inhibitors App 20120258513 - Silverman; Richard B. ; et al.	2012-10-11
Specific nNOS Inhibitors for the Therapy And Prevention Of Human Melanoma App 20120238016 - Myskens, JR.; Frank L. ; et al.	2012-09-20
Heteroaromatic selective inhibitors of neuronal nitric oxide synthase Grant 8,158,658 - Silverman , et al. April 17, 2	2012-04-17
Potent and highly selective heteroaromatic inhibitors of neuronal nitric oxide synthase Grant 7,994,326 - Silverman , et al. August 9, 2	2011-08-09
Heteroaromatic Selective Inhibitors of Neuronal Nitric Oxide Synthase App 20090104677 - Silverman; Richard B. ; et al.	2009-04-23
Heteroaromatic selective inhibitors of neuronal nitric oxide synthase Grant 7,470,790 - Silverman , et al. December 30, 2	2008-12-30
NOS Inhibitors For Treatment Of Motor Deficit Disorders App 20080176907 - Silverman; Richard B. ; et al.	2008-07-24
Potent and highly selective heteroaromatic inhibitors of neuronal nitric oxide synthase App 20080108814 - Silverman; Richard B. ; et al.	2008-05-08
Heteroaromatic selective inhibitors of neuronal nitric oxide synthase App 20050107369 - Silverman, Richard B. ; et al.	2005-05-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.